IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Teva Buys U.S. Generic Drugmaker

10:24 AM MDT | August 4, 2008 | Deepti Ramesh

Teva Pharmaceutical Industries Ltd. (Petach Tikva, Israel) says it has completed the acquisition of Bentley Pharmaceuticals (Exeter, NH) for about $360 million. Bentley produces generic pharmaceuticals, which generated revenues of about $114 million in 2007. Teva expects the acquisition to become accretive to earnings within 12 months. Bentley spun off a drug delivery business to shareholders in June and currently manufactures and markets about 130 pharma products, as well as active pharmaceutical ingredients (APIs) through its subsidiary Bentley API. The...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa